BRAINSWAY: FDA GRANTED EXPANDED INDICATION FOR DEEP TRANSCRANIAL MAGNETIC STIMULATION SYSTEM ALLOWING FOR TREATMENT OF PATIENTS WITH MDD AGES 22 TO 86

Reuters · 06/03 11:30
BRAINSWAY: FDA GRANTED EXPANDED INDICATION FOR DEEP TRANSCRANIAL MAGNETIC STIMULATION SYSTEM ALLOWING FOR TREATMENT OF PATIENTS WITH MDD AGES 22 TO 86